Elfabrio 20 mg/10 mL (2 mg/mL) injection Images
Generic Name: pegunigalsidase alfa
This medication has been identified as Elfabrio 20 mg/10 mL (2 mg/mL) injection. It is supplied by Chiesi USA, Inc.
Elfabrio is used in the treatment of Fabry Disease and belongs to the drug class lysosomal enzymes. Elfabrio 20 mg/10 mL (2 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Elfabrio
- Generic Name
- pegunigalsidase alfa
- Strength
- 20 mg/10 mL (2 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Lysosomal enzymes
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Chiesi USA, Inc.
- National Drug Code (NDC)
- 10122-0160
More about Elfabrio (pegunigalsidase alfa)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: lysosomal enzymes
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
